Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-22T16:06:06.951Z Has data issue: false hasContentIssue false
  • English
  • Français

Reserpine exhumed

Published online by Cambridge University Press:  03 January 2018

David Healy  and
Marie Savage
David Healy*
Affiliation:
North Wales Department of Psychological Medicine, Hergest Unit, Bangor
Marie Savage
Affiliation:
North Wales Department of Psychological Medicine, Hergest Unit, Bangor
*
D. Healy, North Wales Department of Psychological Medicine, Hergest Unit. Bangor. LL57 2PW
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
The British Journal of Psychiatry , Volume 172 , Issue 5 , May 1998 , pp. 376 - 378
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

Achor, R. W. R., Hanton, N. O. & Gifford, R. W. (1955) Hypertension treated with rauwolfia serpentina (whole root) and with reserpine. Controlled study disclosing occasional severe depression. Journal of the American Medical Association, 159, 841–845.CrossRefGoogle ScholarPubMed
Ayd, F. J. (1958) Drug induced depression – fact or fallacy. New York State journal of Medicine. 58, 354–356.Google Scholar
Bernstein, S. & Kaufman, M. R. (1960) A psychological analysis of apparent depression following rauwolfia therapy. Journal of Mount Sinai Hospital, 27, 525–530.Google Scholar
Casta, E., Garrattini, S. & Valzelli, L. (1960) Interactions between reserpine, chlorpromazine and imipramine. Expenentia, 15, 461–463.Google Scholar
Davies, D. L. & Shepherd, M. (1955) Reserpine in the treatment of anxious and depressed patients. Lancet. 11, 117–121.Google Scholar
Deniker, P. (1983) Discovery of the clinical use of neuroleptics. In Discoveries in Pharmacology (eds M. J. Parnham & J. Bruinvels), pp. 163–180. Amsterdam: Elsevier.Google Scholar
Faucett, R. L., Litin, E. M. & Achor, R. W. P. (1957) Neuropharmacologic action of rauwolfia compounds and its psychodynamic implications. American Medical Association Archives of Neurology and Psychiatry, 77, 513–518.CrossRefGoogle ScholarPubMed
Ferguson, J. T. (1955) Treatment of reserpine-induced depression with a new analeptic: phenidylate. Annals of the New York Academy of Sciences. 61, 101–107.Google Scholar
Freis, E. D. (1954) Mental depression in hypertensive patients treated for long periods with large doses of reserpine. New England journal of Medicine, 251, 1006–1008.Google Scholar
Genest, J., Adamkiewicz, L., Robillard, R., et al (1955) Clinical use of reserpine. Canadian Medical Association Journal, 72, 483–489.Google Scholar
Hasse, H.-J. (1958) The role of drug-induced extrapyramidal syndromes. In Psychopharmocology Frontiers (ed. N. S. Kline), pp. 197–208. Boston. MA: Little Brown.Google Scholar
Harris, T. H. (1957) Depression induced by Rauwolfia compounds. American journal of Psychiatry, 113, 950.Google Scholar
Healy, D. (1997) The Antidepressant Era. Cambridge, MA: Harvard University Press.Google Scholar
Healy, D. & Farquhar, G. M. (1998) Immediate effects of droperidol. Human Psychopharmacology, 13, in press.3.0.CO;2-N>CrossRefGoogle Scholar
Jensen, K. (1959) Depressions in patients treated with reserpine for arterial hypertension. Acta Psychiatrica Scondinavica, 34, 195–204.Google Scholar
Kass, I. & Brown, E. B. (1955) Treatment of hypertensive patients with rauwolfia compounds and reserpine: depressive and psychotic changes. Journal of the American Medical Association, 159, 1513–1516.Google Scholar
Lemieux, G., Davignon, A. & Genest, J. (1956) Depressive states during rauwolfia therapy for arterial hypertension. A report of 30 cases. Canadian Medical Association journal, 74, 522–526.Google Scholar
Muller, J. C., Pryor, W. W., Gibbons, J. E., et al (1955) Depression and anxiety occurring during rauwolfia therapy, journal of the American Medical Association, 159, 836–839.CrossRefGoogle ScholarPubMed
Price, L. H., Charney, D. S. & Heninger, G. R. (1987) Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects. Psychophormacology. 92, 431–437.Google Scholar
Sarwar-Foner, G. J. & Ogle, W. (1955) Psychosis and enhanced anxiety produced by reserpine and chlorpromazine. Canadian Medical Association journal, 74, 526–532.Google Scholar
Schroeder, H. A. & Mitchell-Perry, H. (1955) Psychosis apparently produced by reserpine. Journal of the American Medical Association, 59, 839–840.CrossRefGoogle Scholar
Smirk, F. H. & McQueen, E. G. (1955) Comparison of rescinamine and reserpine as hypotensive agents. Lancet. 2, 115–116.Google Scholar
Vakil, R. J. (1949) Clinical trial of Rauwolf la serpentina in essential hypertension. British Heart journal, 2, 350–355.CrossRefGoogle Scholar
Van Putten, T. (1975) The many faces of akathisia. Comprehensive Psychiatry, 16, 43–47.Google Scholar
Wallace, D. C. (1955) Treatment of hypertension. Hypotensive drugs and mental changes. Lancet, 2, 116–117.Google Scholar
Wilkins, R. W. (1954) Clinical usage of rauwolfia alkaloids, including reserpine. Annals of the New York Academy of Sciences, 59, 36–44.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.